mucopolysaccharidosis vi
Recently Published Documents


TOTAL DOCUMENTS

147
(FIVE YEARS 15)

H-INDEX

29
(FIVE YEARS 1)

Author(s):  
Nathalie Guffon ◽  
Pratima Chowdary ◽  
Elisa Leão Teles ◽  
Derralynn Hughes ◽  
Julia B. Hennermann ◽  
...  

2021 ◽  
Author(s):  
Fahrul Nurkolis ◽  
Ronald Rompies ◽  
Bobby Pambudi ◽  
Yoseph Chen ◽  
Nelly Mayulu

2021 ◽  
Vol 133 (1) ◽  
pp. 100-108
Author(s):  
Paula Garcia ◽  
Dawn Phillips ◽  
JoAnn Johnson ◽  
Kenneth Martin ◽  
Linda M. Randolph ◽  
...  

2021 ◽  
Vol 105 (1) ◽  
Author(s):  
Michiel Landen ◽  
François Eyskens ◽  
Filip Vanhoenacker

2020 ◽  
Vol 51 (6) ◽  
pp. 982-986
Author(s):  
K. Raj ◽  
L. Berman‐Booty ◽  
P. Foureman ◽  
U. Giger

PLoS ONE ◽  
2020 ◽  
Vol 15 (5) ◽  
pp. e0233032 ◽  
Author(s):  
Eugeni Entchev ◽  
Ingrid Jantzen ◽  
Philippe Masson ◽  
Stephanie Bocart ◽  
Bruno Bournique ◽  
...  

2020 ◽  
Vol 2020 (1) ◽  
Author(s):  
Darius Khadembaschi ◽  
John Arvier ◽  
Nicholas Beech ◽  
David Dolan ◽  
Jim McGill

Abstract Mucopolysaccharidoses are a group of rare lysosomal storage diseases caused by a deficiency of enzymes, which breakdown glycosaminoglycans, with consequent dysfunction of affected tissues. Mandibular coronoid hyperplasia, with associated trismus, has been recently described as a feature of the craniofacial abnormalities seen in these patients. However, the details of the surgical and post-operative management of these patients have not been previously documented. This case describes the successful management of severe trismus from coronoid process hyperplasia in a 14-year-old male, utilising an extra-oral approach for bilateral coronoidectomies and removal of exophytic zygomatic bone, followed by immediate and long-term physiotherapy. An improvement of mandibular opening from 8 to 45 mm has been maintained at 18 months post operation.


2020 ◽  
Vol 8 ◽  
pp. 2050313X2093824
Author(s):  
Tran Kiem Hao ◽  
Nguyen Thi Diem Chi ◽  
Nguyen Thi Hong Duc ◽  
Nguyen Thi Kim Hoa

Mucopolysaccharidosis is a group of rare metabolic disorders characterized by a deficiency of enzymes in the degradation of glycosaminoglycans. The incomplete degradation process leads to the accumulation of glycosaminoglycans in lysosomes of various tissues, which interferes with cell function. We report three cases that were classified as Hurler—Mucopolysaccharidosis I, Morquio—Mucopolysaccharidosis IV A, and Maroteaux–Lamy—Mucopolysaccharidosis VI. Clinical presentations of these cases vary, depending on each type of enzyme defect. All the patients appeared healthy at birth, and symptoms appear at around 1 or 2 years. Clinical features, radiological findings, and especially enzyme assays have allowed us to establish a definitive diagnosis in these cases. These cases highlight that abnormal clinical symptoms, such as growth failure, coarse facial features, and joint problems, are key points for further investigation relating to mucopolysaccharidosis disease. However, in low- and middle-income countries, it is difficult to have a definitive diagnosis of one of the mucopolysaccharidoses due to lacking enzyme assays.


Author(s):  
Bárbara Bernardo Figueirêdo ◽  
Cyda Reinaux ◽  
Giovanna Domingues Cavalcanti ◽  
Helen Kerlen Fuzari ◽  
Cláudia Thais Pinto ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document